Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1662, 2008-01, pp. : 13-13
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Bevacizumab gives a boost to chemotherapeutics in mCRC
Inpharma, Vol. 1, Iss. 1603, 2007-01 ,pp. :
Access to resources
Recommend
KRAS status predicts response to cetuximab in mCRC
Inpharma, Vol. 1, Iss. 1641, 2008-01 ,pp. :
Cetuximab launched for mCRC, approved for SCCHN.
Inpharma, Vol. 1, Iss. 1663, 2008-01 ,pp. :
Cetuximab extends survival in patients with mCRC
Inpharma, Vol. 1, Iss. 1657, 2008-01 ,pp. :
Cetuximab first line in mCRC: benefits CRYSTAL clear
Inpharma, Vol. 1, Iss. 1593, 2007-01 ,pp. :